Drug interactions
Palifermin + Rituximab
Severity: Minor
Palifermin and Rituximab: minor interaction.
Last updated
For healthcare professionals — reference only. This page is a brief summary, not medical advice and not a substitute for official labeling or clinical judgement. Always verify before prescribing or dispensing.
Summary
Palifermin is a keratinocyte growth factor used to reduce mucositis after cytotoxic chemotherapy or radiation. The cautions about timing relate to cytotoxic chemotherapy, and rituximab is a monoclonal antibody that does not cause mucositis, so no meaningful interaction exists.
What this interaction means in plain words
Palifermin and Rituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised.
Palifermin belongs to Miscellaneous; Rituximab belongs to Musculoskeletal.
Why it happens
No established mechanism; rituximab does not damage the mucosa through the cytotoxic route targeted by palifermin.
What to do
No special action needed for rituximab alone. If given with cytotoxic chemotherapy, follow the palifermin timing rules around that chemotherapy.
What to ask your pharmacist
- Is there anything I should notice while taking both?
- Do I need to tell my doctor at the next visit?
Pro+ members
Unlock the full page
Create an account and start a Pro+ trial to unlock the full management advice for Palifermin and Rituximab, the additional notes, the evidence detail and the whole-prescription interaction checker.
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
Try Pro+ free for 14 days on the web. No card needed.
Other interactions of Rituximab
Other interactions of Palifermin
Frequently asked questions
Can I take Palifermin with Rituximab?
MediHelp rates the interaction as minor. Palifermin and Rituximab have a small, usually unimportant interaction. Most people can take both; the pharmacist may still mention it so that any unexpected effect is recognised. Palifermin is a keratinocyte growth factor used to reduce mucositis after cytotoxic chemotherapy or radiation. The cautions about timing relate to cytotoxic chemotherapy, and rituximab is a monoclonal antibody that does not cause mucositis, so no meaningful interaction exists.
How serious is the interaction between Palifermin and Rituximab?
MediHelp rates it minor, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: No special action needed for rituximab alone. If given with cytotoxic chemotherapy, follow the palifermin timing rules around that chemotherapy.
What other medicines interact with Rituximab?
MediHelp also lists interactions of Rituximab with, for example, Adenovirus types 4 and 7 live, Baricitinib, Certolizumab pegol. The full list is on the Rituximab page.
Full monographs, dosing and an interaction checker in the MediHelp app
Open the complete reference, check multi-drug interactions and use dosing tools in the MediHelp app.
